SOLV
Solventum Corp.
NYSE: SOLV · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$66.49
-1.51% today
Updated 2026-04-29
Market cap
$11.54B
P/E ratio
7.49
P/S ratio
1.39x
EPS (TTM)
$8.88
Dividend yield
—
52W range
$62 – $88
Volume
1.3M
Solventum Corp. (SOLV) Financial statements
SEC filings — annual and quarterly data.
Profit margin
18.70%
Operating margin
7.01%
ROE
38.90%
ROA
2.94%
Debt/equity
1.03x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $7.28B | $1.14B | 59.26% | 19.64% | 15.63% |
| 2021 | $8.17B | $1.46B | 60.25% | 23.00% | 17.87% |
| 2022 | $8.13B | $1.34B | 57.75% | 20.82% | 16.52% |
| 2023 | $8.20B | $1.35B | 57.25% | 20.64% | 16.42% |
| 2024 | $8.25B | $479.00M | 55.65% | 12.55% | 5.80% |
| 2025 | $8.32B | $1.56B | 53.47% | 26.20% | 18.69% |